|
Novel Targeted Therapy for Breast Cancer
|
1R43CA124179-01A1
|
$120,600
|
Serrero, Ginette
|
A AND G PHARMACEUTICAL, INC.
|
|
Clinical study of GMCI in Pancreatic Cancer
|
5R43CA119847-02
|
$376,666
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Fibronectin Polymerization: Effects on Cell Signaling
|
5R01CA069612-11
|
$271,548
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
Signal Transduction and Tumor Angiogenesis
|
5R01CA081419-08
|
$299,625
|
PUMIGLIA, KEVIN
|
ALBANY MEDICAL COLLEGE
|
|
Targeting alpha particle-emitting radionuclides to the nuclei of cancer cells
|
1R41CA126072-01A2
|
$115,953
|
QUINN, THOMAS
|
ALPHAMED, INC
|
|
Processing Ac-227 sources for lead-212 and radium-223 required by cancer research
|
1R41CA124302-01A1
|
$111,300
|
Soderquist, Chuck
|
ALPHAMED, INC
|
|
American College of Radiology Imaging Network
|
5U01CA080098-09
|
$10,637,601
|
HILLMAN, BRUCE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Recovery of RNA from Formalin-Fixed Tissues
|
5R21CA118477-02
|
$143,951
|
O'LEARY, TIMOTHY
|
AMERICAN REGISTRY OF PATHOLOGY, INC.
|
|
Orthotopic models of tumor angiogenesis and blood flow
|
5R44CA099258-03
|
$374,848
|
YANG, MENG
|
ANTICANCER, INC.
|
|
Dual-color tumor-host imaging models
|
5R44CA103563-03
|
$375,784
|
YANG, MENG
|
ANTICANCER, INC.
|
|
Targeting Relaxin Signaling in Prostate Cancer
|
1R21CA118362-01A1
|
$180,000
|
Agoulnik, Alexander
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Hypersensitive ERa Mutant in Breast Cancer Progression
|
5R01CA072038-10
|
$285,759
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Molecular Dissection of Tumor Invasion
|
2R01CA087751-06A2
|
$246,598
|
GOODE, SCOTT
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel Oncolytic HSP Vaccine for Systemic Tumor Therapy
|
5R01CA100841-02
|
$206,823
|
HUANG, XUE
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Prostate Cancer
|
3P50CA058204-13S1
|
$1,124,001
|
ITTMANN, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-03
|
$280,899
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
RNAi-Based Therapy of Hepatocellular Carcinoma
|
5R01CA109574-03
|
$224,720
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Repression by C SKI and Melanoma Progression
|
5R01CA084282-07
|
$264,568
|
MEDRANO, ESTELA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Multiplexed Methods for the Study of Chromosomal Aberrations in Cancer
|
1R33CA114151-01A1
|
$230,510
|
MILOSAVLJEVIC, ALEKSANDAR
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Gene Networks in Breast Development and Cancer
|
5P01CA030195-25
|
$2,383,667
|
Oesterreich, Steffi
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer
|
3P50CA058183-13S1
|
$153,479
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer
|
5P50CA058183-13
|
$2,612,827
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting Oncogene Expression to Skin in Transgenic Mice
|
5R01CA052607-17
|
$490,305
|
Roop, Dennis
|
BAYLOR COLLEGE OF MEDICINE
|
|
INDUCIBLE MOUSE MODELS FOR SKIN AND HEAD AND NECK CANCER
|
5U01CA105491-04
|
$836,418
|
Roop, Dennis
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mouse Models of Human Breast Cancer
|
3U01CA084243-09S1
|
$43,919
|
Rosen, Jeffrey
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mouse Models of Human Breast Cancer
|
5U01CA084243-09
|
$836,156
|
Rosen, Jeffrey
|
BAYLOR COLLEGE OF MEDICINE
|
|
Co-evolution of the Reactive Microenvironment in Prostate Cancer Progression
|
5U54CA126568-02
|
$700,401
|
ROWLEY, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer
|
2R01CA050588-18A2
|
$324,883
|
Thompson, Timothy
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of Metastasis in Experimental Prostate Cancer
|
5R01CA068814-12
|
$289,043
|
Thompson, Timothy
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of SRC-1 in Breast Cancer
|
5R01CA112403-02
|
$258,529
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
STRATEGIES TO ENHANCE VIROTHERAPY FOR BREAST CANCER
|
5R01CA106671-04
|
$234,030
|
ZHANG, XIAOLIU
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-06
|
$978,697
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Regulation of Cell Function by Matricellular Hevin
|
5R01CA109559-04
|
$344,827
|
Wight, Thomas
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-02
|
$333,543
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Blood Flow MRI for Monitoring of Renal Cell Carcinoma
|
5R21CA121570-02
|
$292,999
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Renal Cancer SPORE
|
5P50CA101942-05
|
$2,330,598
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Angiogenesis in Breast Cancer
|
5R01CA106263-03
|
$318,352
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Survival Signaling in Breast Cancer
|
5R01CA109086-04
|
$330,443
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Gene repression by HSF1 during hyperthermia and other stresses.
|
2R01CA077465-04A1
|
$227,020
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Slit in CXCR4-Mediated Breast Cancer Metastasis
|
5R01CA109527-03
|
$254,682
|
GANJU, RAMESH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Choline Metabolism in Prostate Cancers: Response to Dietary Soy Phytochemicals
|
1R21CA130013-01A1
|
$198,280
|
GASTON, SANDRA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of Hemidesmosome Disassembly: Role of a6b4 integrin phosphorylation
|
1R01CA120202-01A1
|
$290,700
|
RABINOVITZ, ISAAC
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Generation of Antiangiogenic Activity for Cancer Treat.
|
5R01CA098948-05
|
$270,081
|
SUKHATME, VIKAS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
|
1R01CA122099-01A1
|
$290,700
|
TOKER, ALEX
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Synergy between phytochemicals for prostate cancer prevention
|
1R03CA130133-01
|
$85,000
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Oldenlandia diffusa for prostate cancer treatment
|
1R21CA133865-01A2
|
$170,000
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A novel biotherapeutic treatment for prostate cancer
|
1R43CA130228-01
|
$145,306
|
CHOI, ANTHONY
|
BEXION PHARMACEUTICALS, INC.
|
|
Circulating Tumor Cells in Non-Small Cell Lung Cancer
|
1R01CA125653-01A1
|
$332,207
|
Nieva, Jorge
|
BILLINGS CLINIC FOUNDATION
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|